H & T Presspart

H & T Presspart, established in 1970, is a specialized pharmaceutical technology company operating within the Medical Devices & Equipment and Manufacturing sectors. It excels in the development and manufacturing of drug delivery devices and precision components for the healthcare industry. The company is recognized for its high-quality solutions that support the safe and effective administration of medicines. H & T Presspart collaborates closely with pharmaceutical and biotech partners, guiding drug-device combination products from initial concept through to large-scale production. Its comprehensive offerings include a wide array of device components, sophisticated delivery systems, and essential technical services aimed at enhancing patient outcomes and expediting product development timelines.

Operating across 5 locations, H & T Presspart reports revenue of $275.8M and employs 1,000-5,000 professionals. Its product range features drug delivery systems, MDI components, actuators, and dispensers, utilizing materials like aluminium alloy and precision injection moulding for high-precision metal and plastic parts. These capabilities are crucial for pharmaceutical applications. To learn more about the people behind these innovations, you can Meet H & T Presspart's team.

The company competes with firms like Owen Mumford and Quotient Sciences, establishing itself as a key player in respiratory drug delivery and medical devices. H & T Presspart's technical expertise includes deep-drawn metal components and precision injection moulding for the pharmaceutical and healthcare markets. Their commitment to regulatory support and innovation ensures adherence to stringent industry standards, contributing to connected inhalers and smart drug delivery solutions.